PT84620B - Processo para a preparacao de novos compostos relacionados com a espergualina - Google Patents

Processo para a preparacao de novos compostos relacionados com a espergualina

Info

Publication number
PT84620B
PT84620B PT84620A PT8462087A PT84620B PT 84620 B PT84620 B PT 84620B PT 84620 A PT84620 A PT 84620A PT 8462087 A PT8462087 A PT 8462087A PT 84620 B PT84620 B PT 84620B
Authority
PT
Portugal
Prior art keywords
espergualina
preparation
compounds
new compounds
immuno
Prior art date
Application number
PT84620A
Other languages
English (en)
Other versions
PT84620A (en
Inventor
Hamao Umezawa
Tomio Takeuchi
Tetsushi Saino
Masao Yoshida
Yoshida Katsutoshi
Teruya Nakamura
Original Assignee
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chem Res Found filed Critical Microbial Chem Res Found
Publication of PT84620A publication Critical patent/PT84620A/pt
Publication of PT84620B publication Critical patent/PT84620B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT84620A 1986-04-04 1987-04-03 Processo para a preparacao de novos compostos relacionados com a espergualina PT84620B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7774786 1986-04-04

Publications (2)

Publication Number Publication Date
PT84620A PT84620A (en) 1987-05-01
PT84620B true PT84620B (pt) 1989-11-30

Family

ID=13642505

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84620A PT84620B (pt) 1986-04-04 1987-04-03 Processo para a preparacao de novos compostos relacionados com a espergualina

Country Status (17)

Country Link
US (1) US4956504A (pt)
EP (1) EP0241797B1 (pt)
JP (1) JPH0745460B2 (pt)
KR (2) KR940006768B1 (pt)
CN (1) CN1016341B (pt)
AT (1) ATE64378T1 (pt)
AU (1) AU599092B2 (pt)
CA (1) CA1305827C (pt)
DE (1) DE3770680D1 (pt)
DK (2) DK171487A (pt)
ES (1) ES2039213T3 (pt)
FI (1) FI86546C (pt)
GR (1) GR3002660T3 (pt)
HU (1) HU204069B (pt)
IE (1) IE60077B1 (pt)
PT (1) PT84620B (pt)
ZA (1) ZA872440B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0794424B2 (ja) * 1987-09-30 1995-10-11 財団法人微生物化学研究会 新スパガリン関連化合物およびその製造法
US5770625A (en) * 1988-02-08 1998-06-23 The Trustees Of Columbia University In The City Of New York Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
US4990536A (en) * 1989-04-03 1991-02-05 Nippon Kayaku Kabushiki Kaisha Immunopotentiator and spergualin-related compound therefor
YU48230B (sh) * 1989-05-29 1997-08-22 Takara Shuzo Co.Ltd. Kristalni deoksispergvalin i postupak za njegovo pripremanje
US5086069A (en) * 1990-02-05 1992-02-04 Rorer Pharmaceutical Corporation Anti-thrombotic peptide and pseudopeptide derivatives
EP0467280B1 (en) * 1990-07-20 1994-09-28 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compound and use thereof
AU661659B2 (en) * 1991-04-11 1995-08-03 Rhone-Poulenc Rorer International (Holdings) Inc. Anti-thrombotic peptide and pseudopeptide derivatives
WO1994004140A1 (en) * 1992-08-19 1994-03-03 Nippon Kayaku Kabushiki Kaisha Antiprotozoan drug
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
GB9726569D0 (en) * 1997-12-16 1998-02-11 Univ Southampton Neuroprotective agents
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
KR100604206B1 (ko) * 2005-12-01 2006-07-24 박현미 배선용 단자

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5748957A (en) * 1980-09-08 1982-03-20 Microbial Chem Res Found Novel antibiotic bmg 162-af2, its preparation and carcinostatic agent comprising it as active ingredient
JPS57185254A (en) * 1981-05-11 1982-11-15 Microbial Chem Res Found Novel carcinostatic substances and their preparation
JPS5862152A (ja) * 1981-10-08 1983-04-13 Microbial Chem Res Found N−〔4−(3−アミノプロピル)アミノブチル〕−2−(ω−グアニジノ脂肪酸アミド)−2−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
US4525299A (en) * 1983-05-10 1985-06-25 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai (-)-15-Deoxyspergualin, process for the preparation thereof, and intermediate of the same
JPS60104099A (ja) * 1983-11-09 1985-06-08 Nippon Kayaku Co Ltd スパガリン関連化合物の新規製造法
JPS60181056A (ja) * 1984-02-29 1985-09-14 Takara Shuzo Co Ltd Ν−〔4−(3−アミノプロピル)アミノブチル〕−2,2−ジヒドロキシエタンアミドの製造法
JPS60185758A (ja) * 1984-03-02 1985-09-21 Microbial Chem Res Found フエニレン基を有するスパガリン関連化合物およびその製造法
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
AU587691B2 (en) * 1987-03-30 1989-08-24 Shosuke Okamoto Phenylalanine derivative and proteinase inhibitor

Also Published As

Publication number Publication date
FI871445A0 (fi) 1987-04-02
CN87102538A (zh) 1987-11-18
EP0241797A3 (en) 1988-07-20
EP0241797A2 (en) 1987-10-21
DK102792D0 (da) 1992-08-18
KR870009989A (ko) 1987-11-30
GR3002660T3 (en) 1993-01-25
FI86546C (fi) 1992-09-10
CA1305827C (en) 1992-07-28
US4956504A (en) 1990-09-11
DK102792A (da) 1992-08-18
FI86546B (fi) 1992-05-29
HU204069B (en) 1991-11-28
AU599092B2 (en) 1990-07-12
ZA872440B (en) 1987-12-30
DK171487D0 (da) 1987-04-03
JPS6345247A (ja) 1988-02-26
HUT44577A (en) 1988-03-28
IE870864L (en) 1987-10-04
IE60077B1 (en) 1994-06-01
DK171487A (da) 1987-10-05
ES2039213T3 (es) 1993-09-16
PT84620A (en) 1987-05-01
FI871445A (fi) 1987-10-05
KR890001965A (ko) 1989-04-06
AU7107587A (en) 1987-10-08
JPH0745460B2 (ja) 1995-05-17
CN1016341B (zh) 1992-04-22
EP0241797B1 (en) 1991-06-12
KR940006768B1 (ko) 1994-07-27
KR940007743B1 (ko) 1994-08-24
DE3770680D1 (de) 1991-07-18
ATE64378T1 (de) 1991-06-15

Similar Documents

Publication Publication Date Title
FI884626A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
ATE51621T1 (de) Bicyclische kondensierte n-(4-piperidinyl)-2imidazolamin-derivate.
EP0269574A3 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
PT82824B (pt) Processo para a preparacao de (4-piperidinilmetil e-hetero)purinas
PT89769B (pt) Processo para a preparacao de derivados do acido 3-alcenil-1-azabiciclo-{3,2,0}hept-2-eno-2-carboxilico
PT96916A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um macrolido
PT84620B (pt) Processo para a preparacao de novos compostos relacionados com a espergualina
PT82368B (pt) Processo para a preparacao de n-{(4-piperidinil)-alquil}-oxazolaminas e n-{(4-piepridinil)-alquil}-tiazolaminas biciclicas condensadas substituidas
ES552593A0 (es) Un procedimiento para preparar derivados de aminoacidos
GR3018096T3 (en) Polypeptide comprising repeated cell-adhesive core sequences.
PT90725A (pt) Processo para a preparacao de novos compostos cefem
PT81229B (pt) Processo para a preparacao de 1,3-dimetil-1h-purino-2,6-dionas contendo 1h-indol-3-ilo e de composicoes farmaceuticas contendo estes compostos
FI65990C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara aminosyraderivat
PT80791A (fr) Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
SE8601799L (sv) (-)-1beta-etyl-1alfa-hydroximetyl-1,2,3,4,6,7,12,12balfa-iktahydroindolo/2,3-a/-kinolizin, forfarande for dess framstellning och farmaceutiska beredningar innehallande densamma
ES533657A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
ES8801291A1 (es) Un procedimiento para la preparacion de nuevos derivados de beta-lactama.
DK400385A (da) Arphameninderivater, fremgangsmaade til deres fremstilling samt anvendelse heraf som laegemiddel

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19961130